Skip to content

Correlation study between serum Metrnl levels and non-valvular atrial fibrillation

Correlation study between serum Metrnl levels and non-valvular atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106387
Enrollment
Unknown
Registered
2025-07-23
Start date
2025-07-27
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

NVAF patient group:None
Non-NVAF control group:None

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: NVAF patient group: meet the diagnostic criteria for non-valvular atrial fibrillation, exclude other obvious heart diseases (such as rheumatic heart disease, history of cardiac surgery, etc.). Non-NVAF control group: no atrial fibrillation, matching the age, gender, and other underlying characteristics of the patient group.

Exclusion criteria

Exclusion criteria: 1. Patients with rheumatic valvular heart disease; 2. Patients who underwent biological valve or mechanical valve replacement; 3. Severe hepatic and renal insufficiency (alanine aminotransferase and aspartate aminotransferase greater than 3 times the upper limit of normal, glomerular filtration rate <60mL/min/1.73m^2); 4. Lactation or pregnancy; 5. Thyroid dysfunction; 6. Malignant tumors, strokes, immune system diseases, and mental illness at the same time; 7. Recent history of trauma and major surgical procedures.

Design outcomes

Primary

MeasureTime frame
Meteorin-like protein;

Countries

China

Contacts

Public ContactPeng Qing

The Affiliated Hospital of Southwest Medical University

qingpeng9712118@163.com+86 181 8187 3310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026